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In 2012, a novel coronavirus, initially named as human coronavirus EMC (HCoV-EMC) but recently renamed as Middle East 
respiratory syndrome human coronavirus (MERS-CoV), was identified in patients who suffered severe acute respiratory infec-
tion and subsequent renal failure that resulted in death. Ongoing epidemiological investigations together with retrospective 
studies have found 61 laboratory-confirmed cases of infection with this novel coronavirus, including 34 deaths to date. This 
novel coronavirus is culturable and two complete genome sequences are now available. Furthermore, molecular detection and 
indirect immunofluorescence assay have been developed. The present paper summarises the limited recent advances of this 
novel human coronavirus, including its discovery, genomic characterisation and detection. 
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Coronaviruses, a genus in the family Coronaviridae (order 
Nidovirales), are a large family of viruses that can cause 
respiratory, enteric, hepatic, nephric and neurological dis-
eases with variable severity in humans and animals. In hu-
mans, diseases caused by coronaviruses range from the 
common cold to severe acute respiratory syndrome (SARS). 
Based on genome sequence analyses, coronaviruses are 
phylogenetically divided into three genera known as Alph-, 
Beta- and Gammacoronavirus. Betacoronavirus contains 
four subgroups, named 2a, 2b, 2c and 2d. A fourth genera, 
provisionally named Deltacoronavirus, comprises a number 
of recently identified coronaviruses mainly from birds. 
Alph- and Betacoronavirus hosts are predominantly domes-
tic mammalian animals and humans, including swine 
(transmissible gastroenteritis virus, TGEV; porcine epi-
demic diarrhoea virus, PEDV), bovine (bovine coronavirus, 
BCoV), mice (mouse hepatitis virus, MHV), dog (canine 
coronavirus, CCoV), cat (feline infectious peritonitis virus, 
FIPV) and bat (bat coronavirus HKU4, BatCoV-HKU4). 
Human coronaviruses (HCoVs) known so far include 
HCoV-229E, HCoV-OC43, HCoV-HKU1, HCoV-NL63 
and SARS (SARS-CoV). Gammacoronavirus comprises 
primarily avian infectious bronchitis virus (IBV) and beluga 
whale coronavirus SW1 (BWCoV-SW1) [1]. The emerging 
of new coronaviruses has been expanding the taxonomic 
diversity of coronavirus.  
There are several factors resulting in new coronaviruses 
or subtypes continual emerging. These factors include the 
infidelity of RNA-dependent RNA polymerase (RdRp), a 
high gene mutation and recombination rates, the occurrence 
of site-specific or random mutations via a template switch-
ing mechanism during RNA replication and transcription, 
together with a large viral genome and a wide range of hosts. 
684 Geng H Y, et al.   Sci China Life Sci   August (2013) Vol.56 No.8 
In addition, these factors facilitate adaptation to new hosts 
and ecological niches that may cause zoonotic diseases 
events. 
Several new coronaviruses have been identified in the 
past decade, e.g., SARS-CoV outbroke during 2002–
2003 [2]; HCoV-NL63 and HCoV-HKU1 isolated in 2004 
[3] and in 2005 [4] respectively; the SARS-like-CoVs iso-
lated from bats [5]; the alpaca coronavirus (ACoV) isolated 
in 2007 [6] and the novel rabbit coronavirus HKU14 isolat-
ed from domestic rabbits in 2012 [7]. It is worth noting that 
in June 2012, a novel human coronavirus, Middle East res-
piratory syndrome human coronavirus (MERS-CoV), was 
isolated in the Middle East and to date 34 of the 61 labora-
tory-confirmed cases of MERS-CoV infection have died as 
of June 14th (www.who.org) [8,9]. The present paper sum-
marises recent advances in MERS-CoV isolation, genome 
characterisation and molecular detection. 
1  Identification of MERS-CoV  
1.1  Case 1 
In June 2012, a Saudi man in his sixties got an acute respir-
atory tract infection in Saudi Arabia with symptoms of fever, 
cough, expectoration and shortness of breath. The patient 
who was previously well, was severely ill and presented 
with acute pneumonia and later renal failure with a fatal 
outcome 11 days after hospitalization [10]. Clinical speci-
mens were collected and the patient’s sputum was used to 
inoculate Vero and LLC-MK2 cells for viral culture. Cyto-
pathic effect (CPE) was observed and, upon passaging of 
the culture supernatant to fresh cells, the same CPE was 
observed, suggesting viral replication. All known respirato-
ry tract pathogens including the influenza A virus, influenza 
B virus, adenovirus, enterovirus, parainfluenza viruses types 
13, respiratory syncytial virus, human metapneumovirus, 
human bocavirus, rhinovirus, and human herpesvirus types 
13 were tested and all yielded negative results from the 
sputum and cell culture supernatant. However, the pan- 
coronavirus real-time reverse transcription polymerase 
chain reaction (RT-PCR) assay used to detect coronaviruses 
revealed the expected size of the PCR fragments, and found 
that they corresponded to a conserved region of ORF1b of 
the replicase gene of a coronavirus. Phylogenetic analysis of 
this fragment with other known coronaviruses genes 
showed that this novel virus together with the bat corona-
viruses HKU4 and HKU5 belonged to subgroup 2c of the 
linage Betacoronavirus, indicating the emergence of a novel 
coronavirus [11]. The complete genome of the virus was 
subsequently sequenced at the Erasmus Medical Cerner 
(EMC) in Rotterdam in the Netherlands and was named 
human coronavirus EMC (HCoV-EMC), later named 
MERS-CoV (GenBank accession number: JX869059). 
1.2  Case 2 
On 11 September 2012, a Qatari man in his forties with se-
vere respiratory illness was transferred from Qatar to a 
United Kingdom hospital and was admitted to the intensive 
care unit for progressive hypoxia and renal failure. Exten-
sive diagnostic tests on upper and lower respiratory tract 
samples for a causative agent were negative. The pan- 
coronavirus RT-PCR assay, however, yielded a correct band 
size (208 bp) that corresponded to the conserved RNA de-
pendent RNA polymerase gene of coronavirus in lower res-
piratory tract specimens. Assays for detection of known 
human coronaviruses HCoV-OC43, -229E, -NL63, -HKU1 
and SARS-CoV were negative [12]. A comparison of the 
PCR fragment sequence with the nucleotide sequence of 
HCoV-EMC isolated from case 1, showed that they shared 
99% identity, indicating the same viral infection. Subse-
quently, the complete genome sequence of this virus was 
sequenced in London and called Betacoronavirus England 1 
(GenBank accession number: KC164505) [13]. 
1.3  More Cases 
In retrospective studies, two cases of infection with MERS- 
CoV in Jordan were confirmed. These cases were discov-
ered by testing stored specimens from a cluster of pneumo-
nia cases in healthcare workers that occurred in April 2012. 
Both of the confirmed cases have died. To date, a total of 46 
laboratory confirmed cases have been reported in Saudi 
Arabia (including 28 deaths). Jordan, Qatar, the United Ar-
ab Emirates (UAE), France, Germany, Italy, Tunisia and the 
United Kingdom also reported laboratory-confirmed cases. 
The common features of confirmed MERS-CoV infection 
are fever, cough, shortness of breath presented with acute 
pneumonia. Acute renal failure occurred in fatal cases.  
2  Genome characterisation and phylogenetic 
analysis  
Coronaviruses are the largest known enveloped positive- 
stranded RNA viruses, ranging in length from 26 to 32 kb. 
A terminal cap at the 5′ end is followed by a leader se-
quence of 65–98 nucleotides (nt), and an untranslated re-
gion (UTR) of 200–600 nt. The leader sequence is present 
at the 5′ end of all subgenomic mRNAs. Another UTR of 
200–500 nt is at the 3′ end of the genome followed by a 
poly(A) tail of variable length. 5′-UTR contains the signals 
for genome replication, transcription and encapsidation, 
whereas the 3′-UTR contains transcription termination sig-
nals [14]. At the 5′ end nearly two-thirds of the genome 
encode two large overlapping open reading frames (ORF), 
ORF1a and ORF1b. When the coronavirus enters the host 
cell, ORF1a and ORF1b are first translated into two large 
polyproteins, pp1a and pp1ab. Production of pp1ab requires 
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a programmed 1 ribosomal frameshift between the ORF1a 
and ORF1b junction. These polyproteins are processed au-
toproteolytically and subsequently form a transcription- 
replication complex [15]. About one-third of the genome at 
the 3′ end encodes four structural proteins, named the spike 
protein (S), envelop protein (E), small membrane protein 
(M) and the nucleocapsid protein (N). These structural pro-
teins are present in all known coronaviruses. The general 
genome organisation of coronaviruses is as follows: 5′- 
UTR-1a/1b-spike (S)-envelope (E)-membrane (M)-nucl- 
eocapsid (N)-3′-UTR. Among the structural proteins are 
several small group-specific ORFs, which differ markedly 
in number and gene order, but are conserved within the 
same group. These small ORFs are dispensable for viral 
replication in vitro, but determine viral pathogenesis [16]. 
The novel coronavirus MERS-CoV is culturable and two 
complete genome sequences are now available. The com-
plete genome sequence of the novel MERS-CoV contains 
30119 nt and at least 10 predicted ORFs, which is similar to 
other HCoVs. The 5′-UTR and 3′-UTR contain 278 and 300 
nt, respectively. Near the 5′ end, about 3/4 of the genome is 
occupied by two large ORFs, ORF1a (27913433 nt) and 
ORF1b (1343321514 nt). These two ORFs are translated 
from genomic mRNA to produce polyproteins pp1a and 
pp1ab by ribosomal frameshifting at the junction of ORF1a 
and ORF1b, with nt 13427 to 13433 predicted to form the 
“slippery sequence” (5′- UUUAAAC-3′) to produce poly-
proteins pp1ab. Downstream of ORF1b, the genome en-
codes four structure proteins, including the spike (S), enve-
lope (E), membrane (M) and nucleocapsid (N) [17]. Four 
small non-structural ORFs (3a, 3b, 3c, 3d) lie between the S 
and E genes. The gene order of MERS-CoV is as follows: 
5′-UTR-1a/1b-S-ORF3 (formed to 3a, 3b, 3c, 3d)-E-M-N- 
3′-UTR, which most closely resembles the gene structure of 
BatCoV-HKU4 and BatCoV-HKU5 (Figures 1 and 2). 
3  Laboratory detection of MERS-CoV 
To date, at least three real-time (RT-PCR) assays to screen  
and confirm MERS-CoV infection have been developed by 
Europe laboratories. The first RT-PCR screening assay (upE 
assay) was developed to target regions upstream of the E 
gene (27458–27550 nt), with sensitivity of 3.4 copies per 
reaction. Subsequently, a confirmatory assay targeting the 
ORF1b gene was developed, which does not overlap with 
the pan-coronavirus RT-PCR assays [18]. A third, confirm-
atory real-time RT-PCR assay, developed in Europe labor-
atories, targeted the ORF1a (1a assay) and its sensitivity 
was slightly lower than that of the upE assay. Furthermore, 
an immunofluorescence assay (IFA) to detect the antibody 
response was developed using convalescent patient serum 
that was biologically safe [19]. The upE assay used in com-
bination with the 1a assay has been reported to provide a 
rigorously validated and highly sensitive result [20]. We 
have designed several primers and probes for real-time 
RT-PCR, modified using locked nucleic acid (LNA), to 
target the ORF1b gene with validated high sensitivity and 
no cross-reaction with HCoV-229E, -OC43, -NL63, -HKU1 
and other respiratory pathogens [21]. The primers and 
probes designed in our laboratory and Europe laboratories 
are shown in Table 1. 
4  Summary  
To date, a total of 61 laboratory-confirmed cases of infec-
tion with MERS-CoV have been reported from Jordan, Qa-
tar, Saudi Arabi, the United Arab Emirates (UAE), France, 
Germany, Italy and the United Kindom, including 34 deaths. 
The clinical presentation of acute pneumonia and renal fail-
ure observed in the fatal cases resembled SARS-CoV that 
outbroke in 20022003. MERS-CoV does not use the angi-
otensin converting enzyme 2 (ACE2) as a receptor for cell 
entry but maintains broad replicative capability in mamma-
lian cell lines from bats, pigs and humans, indicating that 
MERS-CoV is different from SARS-CoV [22]. Phylogenet-
ically, however, HCoV-EMC is most closely related to the 
bat coronaviruses HKU4 and HKU5 in the same Betacoro-
navirus genus as SARS-CoV, indicating a zoonotic origin   
 
 
Figure 1  Genome structure of MERS-CoV, BatCoV-HKU4 and SARS-CoV. Phylogenetic analysis based on the full-length genome sequence of 
MERS-CoV and other known coronaviruses with available complete genome sequences show that MERS-CoV is in subgroup 2c of the genus Betacorona-
virus, close to BatCoV-HKU4 and BatCoV-HKU5 (Figure 2).  
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Figure 2  Phylogenetic tree analysis of MERS-CoV (original name HCov-EMC) based on full-length genome sequence. Alignments were performed using 
ClustalW and the tree was constructed using the neighbor-joining method with bootstrap value (1000 replications). TGEV, porcine transmissible gastroenter-
itis virus; PEDV, porcine epidemic diarrhoea virus; IBV, avian infectious bronchitis virus; BWCoV, beluga whale coronavirus sw1; MHV, mouse hepatitis 
virus; FIPV, feline infectious peritonitis virus; BCoV-HKU4, bat coronavirus HKU4; BCoV-HKU5, bat coronavirus HKU5. 
Table 1  Primers and probes used for screening MERS-CoV infection using real time RT-PCRa) 














































a) *, ORF1b: primers and probe designed for real-time RT-PCR in our laboratory; **, ORF1b-P: probe modification using locked nucleic acid (LNA). 
[23]. Although experimental detection assays have been 
developed, no vaccine or antiviral drug for prevention and 
treatment of MERS-CoV infection is available because only 
limited cases have been reported thus far. The original source, 
pathogen biology, transmission and clinical impact of the 
MERS-CoV infection requires further investigation. 
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